Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method
- PMID: 22388869
- DOI: 10.1002/jps.23090
Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method
Abstract
It has been reported that values of tissue-plasma ratios (K(p)) and resulting volume of distribution at steady state (V(ss)) are substantially overpredicted for several highly lipophilic drugs. This effect was observed particularly with the published version of the tissue-composition-based model, which used experimentally determined unbound fraction in plasma (fu(p)) as input for drugs. The reasons for the unreasonably high V(ss) predictions were investigated in this study for 14 highly lipophilic compounds with a log n-octanol-water partition coefficient (log P(ow)) of at least 5.8. Here, we argue that the experimentally determined fu(p) is inaccurate for these compounds, which affected the prediction of K(p) and V(ss). Alternatively, the tissue-plasma ratio of neutral lipids (nl) equivalent was used as the main factor governing K(p), and hence V(ss), in addition to log P(ow). The average fold error of deviation between the predicted and observed human V(ss) is 124 for the published model, whereas it significantly decreased to 1.5 for the proposed model. The sensitivity analysis confirmed the importance of nl content and drug lipophilicity. Overall, this study proposes a generic and simplified tissue-composition-based model for highly lipophilic drugs and chemicals, which is a step forward toward improving prediction of V(ss) into physiologically based pharmacokinetic (PBPK) models.
Copyright © 2012 Wiley Periodicals, Inc.
Similar articles
-
Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.Drug Metab Dispos. 2019 Oct;47(10):1050-1060. doi: 10.1124/dmd.119.087973. Epub 2019 Jul 19. Drug Metab Dispos. 2019. PMID: 31324699 Free PMC article.
-
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.J Pharm Sci. 2002 Jan;91(1):129-56. doi: 10.1002/jps.10005. J Pharm Sci. 2002. PMID: 11782904
-
On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.J Pharm Sci. 2011 Jun;100(6):2482-97. doi: 10.1002/jps.22444. Epub 2011 Jan 19. J Pharm Sci. 2011. PMID: 21254063
-
Prediction of human pharmacokinetics--evaluation of methods for prediction of volume of distribution.J Pharm Pharmacol. 2007 Sep;59(9):1181-90. doi: 10.1211/jpp.59.9.0001. J Pharm Pharmacol. 2007. PMID: 17883888 Review.
-
Prediction of volume of distribution at steady state in humans: comparison of different approaches.Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):855-72. doi: 10.1517/17425255.2012.682569. Epub 2012 May 17. Expert Opin Drug Metab Toxicol. 2012. PMID: 22591253 Review.
Cited by
-
The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.Toxics. 2023 Oct 21;11(10):874. doi: 10.3390/toxics11100874. Toxics. 2023. PMID: 37888724 Free PMC article. Review.
-
Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data.Front Pharmacol. 2023 Mar 23;14:1165770. doi: 10.3389/fphar.2023.1165770. eCollection 2023. Front Pharmacol. 2023. PMID: 37033641 Free PMC article.
-
Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using in silico, in vitro and human biomonitoring data.Front Pharmacol. 2023 Feb 20;14:1140852. doi: 10.3389/fphar.2023.1140852. eCollection 2023. Front Pharmacol. 2023. PMID: 36891271 Free PMC article.
-
Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study.Toxicol Sci. 2023 Mar 20;192(1):59-70. doi: 10.1093/toxsci/kfad007. Toxicol Sci. 2023. PMID: 36637193 Free PMC article.
-
PBPK Modeling to Simulate the Fate of Compounds in Living Organisms.Methods Mol Biol. 2022;2425:29-56. doi: 10.1007/978-1-0716-1960-5_2. Methods Mol Biol. 2022. PMID: 35188627
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
